Vivos Therapeutics (VVOS) said Wednesday it struck a deal to buy the operating assets of The Sleep Center of Nevada for up to $9 million, including $6 million in cash and $1.5 million in shares.
The transaction, expected to close in Q2 or Q3, does not require Vivos shareholder approval, the company said. It plans to secure funding with a senior debt facility, and potential equity financing.
With the acquisition, the company said it plans to make its treatments for obstructive sleep apnea available to thousands of patients in the greater Las Vegas metro area.
Price: 2.10, Change: -0.09, Percent Change: -4.11
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。